Citadel Advisors
SGHT icon

Citadel Advisors’s Sight Sciences SGHT Stock Holding History

Citadel Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,200
Closed -$36.5K – 14803
2025
Q1 		$36.5K Sell
15,200
-19,600
-56% -$55.2K ﹤0.01% 12625
2024
Q4 		$127K Buy
34,800
+7,500
+27% +$34.2K ﹤0.01% 11112
2024
Q3 		$172K Buy
27,300
+27,000
+9,000% +$182K ﹤0.01% 10372
2024
Q2 		$2K Sell
300
-1,900
-86% -$11.2K ﹤0.01% 13749
2024
Q1 		$11.6K Buy
+2,200
New +$10.3K ﹤0.01% 13400
2023
Q2 		– Sell
-4,000
Closed -$35K – 15122
2023
Q1 		$35K Buy
4,000
+200
+5% +$2.22K ﹤0.01% 12587
2022
Q4 		$46.4K Buy
+3,800
New +$36.1K ﹤0.01% 12231

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Citadel Advisors's SGHT Position: Q1 2026 in Review

Citadel Advisors reduced its Sight Sciences (SGHT) stake by 8.5% in Q1 2026, selling an estimated $67.6K and leaving 135,303 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #9255.

Citadel Advisors first reported a position in SGHT in Q3 2021 and has held it in 14 quarters since. The position peaked at $4.73M in Q4 2021. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Citadel Advisors held 135,303 shares of Sight Sciences worth $510K as of Q1 2026.
  • Citadel Advisors sold 12,535 Sight Sciences shares in Q1 2026, an estimated $67.6K.
  • Sight Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9255 holding.
  • Citadel Advisors first reported a position in Sight Sciences in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Sight Sciences position peaked at $4.73M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.